Evaluation of Antibody Response Directed against Porcine Reproductive and Respiratory Syndrome Virus Structural Proteins

  • 03/06/2022
  • Comments off

Hung Q. Luong, Huong T. L. Lai, and Hiep L. X. Vu Luciferase-immunoprecipitation system (LIPS), a liquid phase immunoassay, was used to evaluate antibody responses directed against the structural proteins of PRRSV in pigs that were experimentally infected with virulent PRRSV strains. First, the viral N protein was used as a model antigen to validate the assay. The […]

Read More

Host Transcriptional Response to Persistent Infection with a Live-Attenuated Porcine Reproductive and Respiratory Syndrome Virus Strain

  • 03/06/2022
  • Comments off

Jayeshbhai Chaudhari, Chia-Sin Liew, Aspen M Workman, Jean-Jack M Riethoven, David Steffen, Sarah Sillman, Hiep L X Vu Both virulent and live-attenuated porcine reproductive and respiratory syndrome virus (PRRSV) strains can establish persistent infection in lymphoid tissues of pigs. To investigate the mechanisms of PRRSV persistence, we performed a transcriptional analysis of inguinal lymphoid tissue collected from pigs experimentally infected with […]

Read More

Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine

  • 03/06/2022
  • Comments off

Haiyan Sun, Jung-Hyang Sur, Sarah Sillman, David Steffen, Hiep L X Vu The substantial genetic diversity exhibited by influenza A viruses of swine (IAV-S) represents the main challenge for the development of a broadly protective vaccine against this important pathogen. The consensus vaccine immunogen has proven an effective vaccinology approach to overcome the extraordinary genetic diversity of RNA viruses. […]

Read More

Synaptogyrin-2 influences replication of Porcine circovirus 2

  • 03/06/2022
  • Comments off

Lianna R. Walker,Taylor B. Engle,Hiep Vu,Emily R. Tosky,Dan J. Nonneman,Timothy P. L. Smith,Tudor Borza,Thomas E. Burkey,Graham S. Plastow,Stephen D. Kachman,Daniel C. Ciobanu Porcine circovirus 2 (PCV2) is a circular single-stranded DNA virus responsible for a group of diseases collectively known as PCV2 Associated Diseases (PCVAD). Variation in the incidence and severity of PCVAD exists between […]

Read More

Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus

  • 03/06/2022
  • Comments off

Haiyan Sun, Aspen Workman, Fernando A Osorio, David Steffen, Hiep L X Vu Modified-live virus (MLV) vaccines are widely used to protect pigs against porcine reproductive and respiratory syndrome virus (PRRSV). However, current MLV vaccines do not confer adequate levels of heterologous protection, presumably due to the substantial genetic diversity of PRRSV isolates circulating in the field. To overcome […]

Read More

Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening

  • 03/06/2022
  • Comments off

Aryamav Pattnaik, Nicholas Palermo, Bikash R Sahoo, Zhe Yuan, Duoyi Hu, Arun S Annamalai, Hiep L X Vu, Ignacio Correas, Pavan Kumar Prathipati, Christopher J Destache, Qingsheng Li, Fernando A Osorio, Asit K Pattnaik, Shi-Hua Xiang Zika virus (ZIKV), an emerging arbovirus, has become a major human health concern globally due to its association with congenital abnormalities and neurological diseases. Licensed vaccines or antivirals against ZIKV are currently […]

Read More

Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion

  • 03/06/2022
  • Comments off

Arun S. Annamalai, Aryamav Pattnaik, Bikash R. Sahoo, Ezhumalai Muthukrishnan, Sathish Kumar Natarajan, David Steffen, Hiep L. X. Vu, Gustavo Delhon, Fernando A. Osorio, Thomas M. Petro, Shi-Hua Xiang, Asit K. Pattnaik Zika virus (ZIKV), a mosquito-transmitted flavivirus responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, reemerged in the last decade causing serious human diseases, including microcephaly, congenital malformations, and Guillain-Barré syndrome. Although genomic and phylogenetic analyses suggest that genetic evolution may have […]

Read More

Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2-4 to the induction of protective immunity

  • 03/06/2022
  • Comments off

Kathryn Kimpston-Burkgren, Ignacio Correas, Fernando A Osorio, David Steffen, Asit K Pattnaik, Ying Fang, Hiep L X Vu The minor glycoproteins (GPs) of PRRSV, GP2, GP3, and GP4, form a heterotrimer that is required for viral infectivity, presumably due to its interaction with the key cellular receptor CD163. These 3GPs are encoded by open reading frames (ORFs) 2a, 3 and 4 […]

Read More

Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection

  • 03/06/2022
  • Comments off

Ignacio Correas, Fernando A Osorio, David Steffen, Asit K Pattnaik, Hiep L X Vu Because porcine reproductive and respiratory syndrome virus (PRRSV) exhibits extensive genetic variation among field isolates, characterizing the extent of cross reactivity of immune responses, and most importantly cell-mediated immunity (CMI), could help in the development of broadly cross-protective vaccines. We infected 12 PRRSV-naïve pigs with […]

Read More

Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus

  • 03/06/2022
  • Comments off

Hiep L X Vu, Asit K Pattnaik, Fernando A Osorio Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important viral pathogens currently affecting swine production worldwide. Although PRRS vaccines have been commercially available for over 20 years, the available vaccines are considered inadequately effective for control and eradication of the virus. Major […]

Read More